Showing 1,421 - 1,440 results of 104,429 for search '(( 5 ((((nm decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 2 wt decrease ))', query time: 1.92s Refine Results
  1. 1421
  2. 1422

    Decreased H3K4me3 in Δ cells is not necessarily due to decreased RNA polymerase II loading () ChIP analysis of H3K4me3 and RNA pol II levels on the locus by Klaas W. Mulder (12134)

    Published 2011
    “…</p><p>© 2007 The Author(s)</p> Data are represented as relative to WT. ChIP efficiencies were 2–3% and 0.15–0.2% for H3K4me3 and 8WG16 antibodies, respectively. () Deletion of or lead to a similar decrease in H3K4me3 and transcript levels on the gene. …”
  3. 1423

    PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues. by Hiromi Hyodo (484509)

    Published 2013
    “…One unit means a decrease in OD<sub>620</sub> per second. …”
  4. 1424
  5. 1425

    The expression of genes related to mitochondria was decreased in Pgam2 mice. by Junji Okuda (444322)

    Published 2013
    “…NRF-1: nuclear respiratory factor 1; CD36/FAT: CD36/fatty acid translocase; MCAD: medium-chain acyl coenzyme A dehydrogenase; Cox5a: mitochondrial cytochrome c oxidase subunit Va. …”
  6. 1426
  7. 1427
  8. 1428
  9. 1429
  10. 1430
  11. 1431
  12. 1432

    Acute JMV2959 treatment decreases alcohol preference in rats. by Petra Suchankova (400313)

    Published 2013
    “…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”
  13. 1433
  14. 1434

    Acute JMV2959 treatment decreases alcohol intake in rats. by Petra Suchankova (400313)

    Published 2013
    “…<p>(A) The acute effects of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) administration on alcohol intake was evaluated at 1 hour time interval after both two and five months of voluntary alcohol consumption. …”
  15. 1435
  16. 1436
  17. 1437
  18. 1438

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”
  19. 1439
  20. 1440